☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - September 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for September 2018 (PDF).

This issue advises that valproate medicines must not be used in women of childbearing potential unless the Pregnancy Prevention Programme is in place. The reminder contains links resources and previous drug safety articles.

Also this month, the summary of letters to healthcare professionals includes a copy of information sent regarding the new contraindications and liver monitoring requirements for ulipristal acetate (Esmya®).

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'Drug Safety Update - September 2018' by emailShare 'Drug Safety Update - September 2018' on FacebookShare 'Drug Safety Update - September 2018' on TwitterShare 'Drug Safety Update - September 2018' on MastodonShare 'Drug Safety Update - September 2018' on LinkedInShare 'Drug Safety Update - September 2018' on reddit

atomic-wealth

No Comments to “Drug Safety Update - September 2018”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.